San Francisco-based AI-enabled ambient automation platform Augmedix saw its stock price drop more than 40% after reporting it observed a slowdown in provider purchasing commitments and downgrading its 2024 full-year revenue outlook from $60 to $62 million to $52 to $55 million.
Still, the company beat estimates of its revenue growth, with a 40% increase in the first quarter, to $13.5 million,...
San Francisco-based AI-enabled ambient automation platform Augmedix announced it will be fully integrated into virtual care and communication organization Andor Health’s ThinkAndor platform.
AI-powered ThinkAndor enables virtual provider visits and patient monitoring and allows care teams to collaborate and gain insights from EMRs.
The partnership will enable physician notes to be created...
San Francisco-based Augmedix has progressed from a Google Glass-based clinical documentation startup to a publicly-traded, AI-enabled ambient automation platform that documents patient encounters and generates medical notes that can be transferred to an EHR.
The company, founded in 2012, also provides pre- and post-visit documentation offerings to give providers a more complete digital picture of...
Recently digital clinical documentation company Augmedix landed $40 million through a new IPO. The company, which is trading on Nasdaq under the symbol AUGX, offered a total of 10,000,000 shares of common stock at $4 per share.
According to the release, the underwriters had a 30-day option from the day the stock went public to purchase up to 1.5 million additional shares of common stock at the...
Searching for outbreaks. The long and sometimes muddled tradition of predicting outbreak hot spots by analyzing search engine activity has continued into the COVID-19 era, with Mayo Clinic researchers publishing new findings that suggest strong correlations between certain keywords and case reports. In reviewing data from Jan. 22 to April 6, "face mask," "Lysol" and "COVID stimulus check" had the...
Augmedix, a startup that uses natural language processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and other unnamed investors all contributed.
WHAT THEY DO
Founded in 2012, the startup made a name for itself by outfitting...
When Google Glass was first launched, it was targeted primarily to consumers, the idea being that they would be able to access the web within their line of vision utilizing what was billed as sleek and stylish technology. But it may have found new life in professional settings, including healthcare, where clinicians are using it to increase efficiency.
Dignity Health has been among the first to...
San Francisco-based Augmedix, which makes a smartglass-based remote scribe platform to reduce the amount of time physicians spend on EHR charting, has raised $23 million in a round led by new investors McKesson Ventures and OrbiMed. Previously, the company raised $17 million, and this latest round brings the company’s total funding to over $60 million.
The funds will be used to build out Augmedix...
Ride-sharing company Lyft has partnered with GreatCall, which makes connected health and safety solutions for the aging population to offer a new transportation program. The GreatCall Rides program will provide GreatCall customers with access to Lyft without an app by leveraging GreatCall’s personal operator services. (Customers just have to dial “0” on their Jitterbug phones). The initial pilot...
April was a big month for digital health funding, with 15 more deals coming through, totalling an impressive $220 million and bringing the total funding so far this year to $691 million. As we did in February with Oscar, we're excluding the largest deal, Bright Health's $80 million round, from the total because the company in question is a tech-saavy payer, but not a digital health company per se...
[25] copy.jpg?itok=H5cmzlpJ "Ian Shakil, founder, director and chief strategy officer at Augmedix")
